Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 03-15-2007, 09:40 PM #1
Howardh's Avatar
Howardh Howardh is offline
Member
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Howardh Howardh is offline
Member
Howardh's Avatar
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Default Gene Therapy Cure 4 Parkinson's

advances to stage 2 trial in Q4 2007

Check out the audio on.

http://www.vcall.com/console/Console...nz&tck=NRGX.OB..

or proceed to www.neurologix.net and click on March 12th release of audio

Cure for Parkinson's within three years by way of gene Therapy perhaps?

The results are encouraging..

GO HARD........ SCIENCE

Last edited by Howardh; 03-15-2007 at 10:26 PM.
Howardh is offline   Reply With QuoteReply With Quote
Old 03-20-2007, 05:33 PM #2
Howardh's Avatar
Howardh Howardh is offline
Member
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Howardh Howardh is offline
Member
Howardh's Avatar
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Thumbs up Gene Therapy

is not as sexy as ESCR and that is possibly the reason why we don't give it the same coverage.

Gene Therapy is set to explode over the next five years. Maybe we need to take notice going by how far advanced and successful Neurologix are with their Parkinson's trials..

Check out

http://www.stemcellresearchnews.com/...earch_news.htm


GO HARD........SCIENCE
Howardh is offline   Reply With QuoteReply With Quote
Old 03-22-2007, 05:31 AM #3
Teretxu's Avatar
Teretxu Teretxu is offline
Member
 
Join Date: Sep 2006
Location: Asturias, Spain
Posts: 172
15 yr Member
Teretxu Teretxu is offline
Member
Teretxu's Avatar
 
Join Date: Sep 2006
Location: Asturias, Spain
Posts: 172
15 yr Member
Default

Good to see you, Rats! Thanks for the links, looks like our friends at Neurologix are doing their homework and everybody else's, too. I'm a sucker for good news on the genetic therapy front!
Teretxu is offline   Reply With QuoteReply With Quote
Old 03-23-2007, 04:02 PM #4
Howardh's Avatar
Howardh Howardh is offline
Member
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Howardh Howardh is offline
Member
Howardh's Avatar
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Smile Hey Tess

i share your thinking on Gene Therapy. This technology has not gotten riddled with the cancer of politics and religion and has therefore been able to develop unhindered too a stage where exciting breakthroughs are likely. Neurologix is an excellent example. Huge advances in the next five years on many fronts, we have got to be excited about that.

The wheels are moving...oh so slowly on ESCR with science being bullied by the pseudo nonsense and spurious claims that religious and political despotic institutes flourish on.

GO HARD SCIENCE

Rats
Howardh is offline   Reply With QuoteReply With Quote
Old 03-23-2007, 09:30 PM #5
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
Default Currently three Gene Therapy initiatives ..

at phase 2/3, Ceregene, Neurologix and the old Avigen initiative.

What I want to know is what happened to Nathan Klein and Dr Michael G. Kaplitt. This dates back to 2003, surely it has moved on from there ? (He says in hope rather than expectation).

Aftermathman (aka Neil, (God only knows why I started this Aftermathman idea anyway)).

<It takes 25 muscles to smile, 45 to frown but only 15 to knock some arse££les lights out.>
aftermathman is offline   Reply With QuoteReply With Quote
Old 03-25-2007, 12:46 AM #6
Howardh's Avatar
Howardh Howardh is offline
Member
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Howardh Howardh is offline
Member
Howardh's Avatar
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Default Hey

Neil, aka Amm,

we won't mention England's Rugby international against Wales. nuff said

Dr Michael Kaplett is a partner in Neurologix along with New Zealand's Dr Mat Dunning. Listen to the Audio in the lead thread.

Nathan Klein...would be interesting to hear how he is progressing.

2003 Gene Therapy trials compared to 2007 Gene Therapy trials is akin to comparing 1930s air travel to 2007 air travel, such is the exponential growth of G.T. in the last four years. The next four years will be compelling.

GO HARD SCIENCE
Howardh is offline   Reply With QuoteReply With Quote
Old 03-28-2007, 07:32 PM #7
Howardh's Avatar
Howardh Howardh is offline
Member
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Howardh Howardh is offline
Member
Howardh's Avatar
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Thumbs up An exciting

update on Gene Therapy and Nathan Klien who is apparently out in the real world doing well after four years of having the initial Gene Therapy treatment.

Check out this powerful report to Wall Street on 03/21/07

http://www.vcall.com/console/Console...nz&tck=NRGX.OB

GO HARD........SCIENCE
Howardh is offline   Reply With QuoteReply With Quote
Old 04-02-2007, 08:21 PM #8
Howardh's Avatar
Howardh Howardh is offline
Member
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Howardh Howardh is offline
Member
Howardh's Avatar
 
Join Date: Sep 2006
Location: New Zealand
Posts: 229
15 yr Member
Default Does

anybody know how Neurologix will screen the 50 to 100 patients to trial their Gene Therapy cure?

No doubt the 100 individuals for these 2007 fourth quarter trials will be from the U.S. There must be murmurings a plenty in this process. And individuals will be lining up for the Neurologix phase 2 trials, particularly since it has been revealed that Nathan Klien is running around with excellent results from his operation in 2003, and exponential improvements on the Gene Therapy from 03 to 07 will have super advanced the technology.

This is powerful stuff.

GO HARD...... SCIENCE
Howardh is offline   Reply With QuoteReply With Quote
Old 04-03-2007, 02:04 AM #9
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
aftermathman aftermathman is offline
Member
 
Join Date: Sep 2006
Location: Evesham, England
Posts: 598
15 yr Member
Default Hi Howard,

hows life in the land of the long white cloud. NZ is lookin' pretty good in the cricket so far.

Don't know of the criteria for this phase but the criteria for phase one was :

Eligibility
Ages Eligible for Study: 25 Years - 75 Years, Genders Eligible for Study: Both
Criteria

Inclusion Criteria:

* Duration of disease: Greater than 5 years
* Idiopathic Parkinson's disease
* Parkinson's medication stable for 3 months
* Absence of dementia
* Hoehn and Yahr rating: 3 or greater and/or UPDRS: 30 or more in "off" state and/or Complications of l-dopa therapy limiting effective use

Exclusion Criteria:

* Poor candidate for any surgery
* Significant dementia
* Secondary parkinsonism
* Severe autonomic symptoms
* Atypical Parkinson's disease
* History of substance abuse



Hope this helps,
Neil.
aftermathman is offline   Reply With QuoteReply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Gene therapy for Lou Gehrig's disease BobbyB ALS 1 08-31-2006 11:52 PM


All times are GMT -5. The time now is 03:45 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.